Unlock instant, AI-driven research and patent intelligence for your innovation.

Apixaban intermediate and preparation method thereof

A technology for apixaban and intermediates, applied in the field of apixaban intermediates and its preparation, can solve the problems of cumbersome post-treatment process, high equipment requirements, and poor reaction repeatability, and achieve low equipment requirements and low cost , post-processing convenient effect

Active Publication Date: 2020-04-17
宁波申泰生物科技有限公司
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] For this reason, the embodiment of the present invention provides an intermediate of apixaban and its preparation method to solve the problem of poor reaction repeatability in the prior art, cumbersome post-treatment process, high requirements for equipment, expensive starting materials, and low cost. advanced questions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Apixaban intermediate and preparation method thereof
  • Apixaban intermediate and preparation method thereof
  • Apixaban intermediate and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0033] An aspect of the embodiments of the present invention provides a method for preparing an intermediate of apixaban, comprising the following steps:

[0034] Step 1. Add 4-chloroaniline and methyl acrylate to the glacial acetic acid solution in turn, heat up and stir, and after the reaction is over, distill under reduced pressure to recover acetic acid, pour the concentrate into water and wash it, extract it with the extraction solvent, concentrate and recover the solvent, and recrystallize After recrystallization from a solvent, Intermediate 2 was obtained;

[0035] Step 2. Dissolve morpholin 4-ylacetic acid and acid chloride reagent in a solvent. After reacting for a certain period of time, add alkali and intermediate 2 obtained in step 1 in turn, react at room temperature, and stop the reaction until 4-chloroaniline disappears. , adding water and an organic solvent for extraction, washing the organic phase with a 1M sodium hydroxide solution, recovering the solvent und...

Embodiment 1

[0051] This example provides a preparation method for intermediate 2: add 50g of 4-chloroaniline and 37g of methyl acrylate to 100mL of glacial acetic acid solution in sequence, raise the temperature to 50°C and stir for 8 hours, the raw materials disappear, and the acetic acid is recovered by distillation under reduced pressure. The concentrate was poured into 100mL water, extracted twice with 100mL dichloromethane, the dichloromethane phases were combined, and the dichloromethane was recovered by distillation under reduced pressure to obtain an oily liquid. The crude product was refluxed with 200mL petroleum ether for 1 hour and filtered to obtain 80g of off-white solid is intermediate 2, with a yield of 95% and a purity of 98%. LC-MS(m / z)214.2[M+H] + .1H NMR (500MHz, DMSO-d6) δ7.09 (d, J = 8.8Hz, 2H), 6, 56 (d, J = 8.8Hz, 2H), 5.82 (t, J = 5.7Hz, 1H), 3.60(s, 3H), 3.25(m, 2H), 2.56(t, J=6.7Hz, 2H).

Embodiment 2

[0053] This example provides a preparation method of intermediate 3: dissolve 58g of morpholin 4-ylacetic acid in 150mL of dichloromethane, control the temperature at 10°C, add 57g of thionyl chloride, react at room temperature for 2 hours, then add 121g Triethylamine reacted for half an hour, then added 80g of intermediate 2 obtained in step (1), and reacted at room temperature for 2 hours. The raw materials were completely reacted, and water and 100mL dichloromethane were added for extraction and layering. After washing with sodium oxide solution, the solvent was recovered under reduced pressure. The obtained crude product was dissolved by heating under reflux with 100 mL of ethanol, and then crystallized at 0°C. After filtration, 125 g of intermediate 3 was obtained as an off-white solid with a yield of 92% and a purity of 97%. LC-MS(m / z)341.4[M+H] + .1H NMR (500MHz, CDCl 3 )δ7.40(d, J=8.6Hz, 2H), 7.15(d, J=8.5, 2H), 3.96(t, J=7.1Hz, 2H), 3.68(t, J=4.2Hz, 4H), 3.61 (s, 3H...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiment of the invention discloses an apixaban intermediate and a preparation method thereof. The preparation method comprises the following steps: preparation of an intermediate 2, preparationof an intermediate 3, preparation of an intermediate 4, preparation of an intermediate 5, and preparation of apixaban key intermediate 5, 6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidyl) phenyl]-2 (1H)-pyridone. According to the apixaban intermediate 5, 6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidyl) phenyl]-2 (1H)-pyridone and the preparation method thereof provided by the invention, the operation is simple, the reaction condition is mild, the requirement on equipment is low, scale-up production is easier, the yield is high, and the purity of the product is greater than 99%.

Description

technical field [0001] The invention relates to the field of chemical industry, in particular to an apixaban intermediate and a preparation method thereof. Background technique [0002] Apixaban (Apixaban), the chemical name is 1-(4-methoxyphenyl)-7-oxo-6[4-(2-oxopiperidin-1-yl)phenyl]-4, 5,6,7-Tetrahydro-1H-pyrazol[3,4-c]pyridine-3-carboxamide, CAS No. 503612-47-3. Apixaban is a potent, orally effective, reversible, direct, and selective active site inhibitor of factor Xa. It has antithrombotic effect and can prevent arterial and venous thrombosis. It was approved for marketing by the European Union in 2011 and officially launched in 2013. Listed in China, it has shown great market competitiveness and potential. [0003] In the current market, there are many synthetic processes for apixaban, but most of the process routes are through its key intermediate 5,6-dihydro-3-(4-morpholinyl)-1-[4- (2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridone is synthesized, therefore, it is very ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/10
CPCC07D401/10
Inventor 陈月春曾琳琳
Owner 宁波申泰生物科技有限公司